Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology

Diagnostic Tests and Evaluations

At a Glance

PRDM8-related progressive myoclonus epilepsy is evaluated with simultaneous EEG and EMG, brain MRI, and sometimes a skin biopsy, but molecular genetic testing—often involving both parents—is the definitive way to confirm the diagnosis.

Because PRDM8-related disorders are rare and can look like other conditions, doctors use a specific set of tests to “see” what is happening in the brain and nerves. These tests help them distinguish between different types of movement issues and confirm the genetic cause.

Specialized EEG: More Than Just a Brain Scan

A standard EEG (electroencephalogram) measures the brain’s electrical activity. However, for conditions involving muscle jerks (myoclonus), doctors often use simultaneous EEG-EMG polygraphy [1].

In this test, the EEG (brain waves) and EMG (electromyogram, which measures muscle activity) are recorded at the exact same time. This allows doctors to:

  • Evaluate the Correlate: It helps an experienced clinician assess whether a movement has a cortical (brain surface) correlate [1]. However, a missing EEG correlate does not unequivocally prove the jerk originated outside the cortex.
  • Catch Discharges: Some individuals with PRDM8 mutations have generalized epileptiform discharges—abnormal electrical patterns in the brain—even if they are not having a physical seizure [2].
  • Map Muscle Patterns: It records how muscles (like the “push” and “pull” muscles in an arm) work together during a jerk [3].

Brain MRI: Looking for Patterns

A Brain MRI creates detailed pictures of the brain’s structure. In the early stages of progressive myoclonus epilepsies, the MRI can often be unremarkable or “normal” [4][5]. This can be frustrating, but it is a common finding in the beginning.

As some related PME conditions progress (though not exclusively documented as universal in PRDM8), an MRI might eventually show changes such as:

  • Atrophy: A “shrinking” or thinning of certain areas, such as the cerebellum (responsible for balance) or the brainstem [4][6].
  • White Matter Changes: Alterations in the tissue that connects different parts of the brain [6].

Repeat imaging is not done on a strict schedule but is ordered based on the clinical course and the treating team’s assessment.

Skin Biopsy: An Optional Clue

When an individual has symptoms that look like Lafora disease, doctors may perform a skin biopsy, usually from the underarm area (axilla) [7].

The goal is to look for Lafora bodies—abnormal clumps of sugar inside the cells. In classic Lafora disease, these are often present. However, in both families documented with PRDM8-related disorders, skin biopsies were negative for these clumps [2]. This is an optional, historical test that does not mandate a PRDM8 diagnosis.

Genetic Testing: The Definitive Answer

While other tests provide clues, molecular genetic testing (such as targeted panels, WES, or WGS) is the definitive way to confirm a PRDM8-related disorder [2].

For the highest chance of a clear answer, doctors often prefer trio-based testing. This means testing the patient and both biological parents at the same time [8]. Trio testing is more powerful because:

  • Inheritance Patterns: It helps doctors see if a genetic change was inherited from parents or if it is a new (de novo) change [8][9].
  • Filtering: It makes it easier for scientists to filter out harmless genetic variations to find the change causing symptoms [10].

Your Completeness Checklist

When navigating a rare diagnosis, patients and families often become the central keepers of medical history. Ensure you have the following reports in a dedicated file:

  • [ ] Genetic Report: The full report from the targeted panel, WES, or WGS, including variant classification and parental testing information.
  • [ ] EEG Reports: Both the “summary” and detailed findings from any video-EEG or polygraphy sessions.
  • [ ] MRI Report: The written radiologist’s report, and ideally, copies of the actual images.
  • [ ] Skin Biopsy Report (Optional): If performed, the pathology report confirming whether or not Lafora bodies (PAS-positive inclusions) were found.
  • [ ] Symptom Diaries: A personal record or videos of concerning movements, seizure logs, or baseline mobility measures.

Common questions in this guide

What test confirms PRDM8-related progressive myoclonus epilepsy?
Molecular genetic testing is the definitive way to confirm a PRDM8-related disorder. A targeted genetic panel, whole-exome sequencing, or whole-genome sequencing may be used, and testing the patient with both biological parents can help clarify the result.
Why are EEG and EMG sometimes done at the same time?
Simultaneous EEG-EMG polygraphy records brain-wave activity and muscle activity at the same time during a jerk. It can help clinicians see whether the movement has a signal from the brain’s surface, identify abnormal brain discharges, and show how muscles work together. A missing EEG signal alone does not prove that the jerk began outside the brain’s surface.
Can a brain MRI be normal in PRDM8-related epilepsy?
Yes. Brain MRI is often normal early in progressive myoclonus epilepsies, so a normal scan does not by itself exclude the condition. If symptoms change, clinicians may repeat imaging; later scans in some related conditions can show shrinkage of the cerebellum or brainstem or changes in white matter.
What does trio genetic testing mean, and why might it help?
Trio testing examines DNA from the patient and both biological parents at the same time. It can show whether a genetic change was inherited or arose newly in the patient and helps filter out harmless genetic differences.
Does a negative skin biopsy rule out a PRDM8-related disorder?
No. Skin biopsy is an optional test sometimes used when Lafora disease is being considered, and the documented PRDM8-related families had no Lafora bodies on biopsy. The result does not replace molecular genetic testing for confirming a PRDM8-related disorder.
What records should I keep for a PRDM8 diagnostic evaluation?
Keep the full genetic report, EEG summaries and detailed tracings, the MRI report and images when available, any skin-biopsy pathology report, and a record or video of movements and seizures. Having parental testing information and symptom dates can help the care team interpret the evaluation.

Get notified when new evidence is published on PRDM8-related progressive myoclonus epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Neurophysiology of myoclonus and progressive myoclonus epilepsies.

    Avanzini G, Shibasaki H, Rubboli G, et al.

    Epileptic disorders : international epilepsy journal with videotape 2016; (18(S2)):11-27 doi:10.1684/epd.2016.0835.

    PMID: 27702708
  2. 2

    The second family affected with a PRDM8-related disease.

    Davarzani A, Shahrokhi A, Hashemi SS, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(6)):3847-3855 doi:10.1007/s10072-021-05815-w.

    PMID: 35034233
  3. 3

    Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K+ channel properties.

    Oliver KL, Franceschetti S, Milligan CJ, et al.

    Annals of neurology 2017; (81(5)):677-689 doi:10.1002/ana.24929.

    PMID: 28380698
  4. 4

    Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease.

    Fang Z, Sun X, Hu Y, et al.

    Frontiers in neuroscience 2026; (20()):1742318 doi:10.3389/fnins.2026.1742318.

    PMID: 41675236
  5. 5

    Case Report: Compound heterozygous KCTD7 variants in two siblings presenting with myoclonic epilepsy and ataxia.

    Song J, Wu W, Tian Y, et al.

    Frontiers in neuroscience 2025; (19()):1670008 doi:10.3389/fnins.2025.1670008.

    PMID: 41311698
  6. 6

    Progressive Myoclonus Epilepsy: Distinctive MRI Changes in Cerebellar and Motor Networks.

    Cameron JM, Mito R, Berkovic SF, Jackson GD

    Annals of clinical and translational neurology 2025; (12(6)):1135-1143 doi:10.1002/acn3.70010.

    PMID: 40211586
  7. 7

    A Case of Lafora Disease Diagnosed by Axillary Skin Biopsy.

    Kimiloğlu E, Akbaş P, Öre ÖE, Turan Ç

    Turk patoloji dergisi 2021; (37(3)):264-265 doi:10.5146/tjpath.2021.01522.

    PMID: 33432562
  8. 8

    The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China.

    Lai G, Gu Q, Lai Z, et al.

    Frontiers in pediatrics 2024; (12()):1448895 doi:10.3389/fped.2024.1448895.

    PMID: 39439447
  9. 9

    A real-world comparison between the diagnostic yield of trio-whole exome sequencing and proband-only targeted exome sequencing in complex childhood epilepsy.

    Fasaludeen A, Jose M, U A, et al.

    Seizure 2025; (129()):51-54 doi:10.1016/j.seizure.2025.03.020.

    PMID: 40220696
  10. 10

    Clinical Utility of Next-Generation Sequencing for Developmental Disorders in the Rehabilitation Department: Experiences from a Single Chinese Center.

    Liu Y, Liu X, Qin D, et al.

    Journal of molecular neuroscience : MN 2021; (71(4)):845-853 doi:10.1007/s12031-020-01707-4.

    PMID: 32959227

This page explains tests used to evaluate PRDM8-related progressive myoclonus epilepsy for informational purposes only and does not constitute medical advice. A neurologist and genetics team should interpret individual results and recommend next steps.